Paroxetine clinical trials
Also written Paxil and Paxil CR.
Includes 4 studies of Paroxetine mesylate.
How each study uses Paroxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Paroxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 1992 · PAXIL · NDA 020031 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
118 studies that test it; most in 2005 (11)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 2 |
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 10 |
| 2003 | 8 |
| 2004 | 9 |
| 2005 | 11 |
| 2006 | 8 |
| 2007 | 2 |
| 2008 | 9 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 47 · Other 74
GlaxoSmithKline (19) · Noven Therapeutics (4) · US Department of Veterans Affairs (4) · Emory University (3) · University of Pittsburgh (3) · Wyeth is now a wholly owned subsidiary of Pfizer (3) · University of California, Irvine (2) · Central South University (2)
Often tested with
Tested in the same studies.
Venlafaxine (6) · Nortriptyline (5) · Duloxetine (5) · Fluvoxamine (4) · Amitriptyline (4) · Sertraline (4) · Citalopram (4) · Mirtazapine (4)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Paroxetine is the comparator. A study of two new drugs counts under both.
- 1Vortioxetine · Federico II University
Reaching primary completion within a year · 1
Studies that test Paroxetine.
- Mar 2027Antidepressant Therapy for Improved Blood Vessel Health After PreeclampsiaEarly Phase 1 · Anna Stanhewicz, PhD
Studies
Open first, then newest update. How each study uses Paroxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 121
- Antidepressant Therapy for Improved Blood Vessel Health After PreeclampsiaRecruitingEarly Phase 1Anna Stanhewicz, PhDNCT07715669Written as Paroxetine HydrochlorideHow we know
- Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus MonotherapyNot yet recruitingNot applicableSouth Valley UniversityNCT07057011Written as Paroxetine 20 Mg Oral TabletHow we know
- The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes MellitusNot yet recruitingPhase 3aya ramadan ashmawy sarhanNCT06203275Written as ParoxetineHow we know
- Management of Acute Tinnitus With Migraine MedicationsSuspendedPhase 4University of California, IrvineNCT06799169Written as ParoxetineHow we know
- Effects of Paroxetine on Cardiovascular Function in Septic PatientsCompletedPhase 2Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da SaudeNCT05725837Written as ParoxetineHow we know
- Concentration-QT Study of Paroxetine in Healthy AdultsCompletedPhase 1GlaxoSmithKlineNCT06065735Written as ParoxetineHow we know
- Transcutaneous Posterior Tibial Nerve Stimulation for Premature EjaculationCompletedNot applicableBoston Medical GroupNCT04207723Written as ParoxetineHow we know
- Paroxetine Safety and Efficacy in Rheumatoid ArthritisCompletedPhase 3Mostafa BahaaNCT06231745Written as ParoxetineHow we know
- Treatment of Tinnitus With Migraine MedicationsCompletedPhase 4University of California, IrvineNCT04404439Written as Verapamil + ParoxetineHow we know
- Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical MenopauseCompletedPhase 2Universidad Nacional Autonoma de HondurasNCT06763484Written as ParoxetineHow we know
- The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis PatientsWithdrawnPhase 1/2Sadat City UniversityNCT04757571Written as ParoxetineHow we know
- Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on VentilationCompletedPhase 1Food and Drug Administration (FDA)NCT05470465Written as Paroxetine and OxycodoneHow we know
- Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy SubjectsCompletedPhase 1Asceneuron S.A.NCT06232109Written as ParoxetineHow we know
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental DisordersCompletedNot applicableCentral South UniversityNCT04218981Written as ParoxetineHow we know
- Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging (fMRI) Study With Paroxetine TreatmentCompletedNot applicableCentral South UniversityNCT03894085Written as ParoxetineHow we know
- Paroxetine Hydrochloride 40 mg Tablets Under Fed ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00841659Written as Paroxetine HClHow we know
- Paroxetine Hydrochloride 40 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00841698Written as Paroxetine HClHow we know
- Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00650403Written as Paroxetine hydrochloride 40 mg tabletHow we know
- Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedEarly Phase 1Mylan Pharmaceuticals IncNCT00648193Written as Paroxetine hydrochloride 40 mg tabletHow we know
- Effects of SERT Inhibition on the Subjective Response to LSD in Healthy SubjectsCompletedPhase 1University Hospital, Basel, SwitzerlandNCT05175430Written as ParoxetineHow we know
See all 121 studies that test Paroxetine →
Given beside what is tested · 10 — Paroxetine is usual care or a partner of the new treatment
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsRecruitingPhase 1/2BioNTech SENCT07070232Written as ParoxetineHow we know
- A Phase I Study of NS-079 in Healthy ParticipantsRecruitingPhase 1NeuShen TherapeuticsNCT07669571Written as ParoxetineHow we know
- Quetiapine Augmentation for Treatment-resistant PTSDCompletedPhase 4VA Office of Research and DevelopmentNCT00292370Written as Open Label (OL) ParoxetineHow we know
- Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)CompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT01360866Written as Paroxetine CRHow we know
- Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.CompletedPhase 2GlaxoSmithKlineNCT00394056Written as Vestipitant + ParoxetineHow we know
- A Combination Therapy In Patients With Social Anxiety DisorderCompletedPhase 2GlaxoSmithKlineNCT00403962Written as vestipitant/paroxetineHow we know
- Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of ClomipheneCompletedPhase 1Robert Bosch Gesellschaft für Medizinische Forschung mbHNCT01289756Written as clomiphene and paroxetineHow we know
- Randomized,Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression DisorderStatus unknownPhase 4Si TianmeiNCT02273154Written as ParoxetineHow we know
- Interpersonal Psychotherapy for Treatment Resistant DepressionStatus unknownNot applicableHospital de Clinicas de Porto AlegreNCT01896349Written as paroxetineHow we know
- Lamotrigine Augmentation in Resistant DepressionCompletedNot applicableLouisiana State University Health Sciences Center in New OrleansNCT00901407Written as paroxetineHow we know
As the comparator · 24 — what is tested is compared with Paroxetine
- Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth SyndromeRecruitingPhase 3Federico II UniversityNCT06025474Written as Paroxetine 20 Mg Oral TabletHow we know
- Lithium Versus Paroxetine in Major DepressionWithdrawnPhase 4Nova Scotia Health AuthorityNCT01416220Written as ParoxetineHow we know
- Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648427Written as Paxil CR™ Tablets 25 mgHow we know
- Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00647881Written as Paxil CR™ Tablets 25 mgHow we know
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentCompletedPhase 4Azienda Ospedaliera Universitaria Integrata VeronaNCT03779789Written as ParoxetineHow we know
- Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or SuicideTerminatedPhase 3Nova Scotia Health AuthorityNCT00400088Written as paroxetineHow we know
- A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic DisorderCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00677352Written as ParoxetineHow we know
- A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)CompletedPhase 3NovartisNCT00463242Written as paroxetineHow we know
- Effects of MNTX on CYP450 2D6 in Metabolizers of DextromethorphanCompletedPhase 1Bausch Health Americas, Inc.NCT01367535Written as Oral ParoxetineHow we know
- Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety DisorderTerminatedPhase 3Cedars-Sinai Medical CenterNCT00836069Written as ParoxetineHow we know
- Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy VolunteersCompletedPhase 4TakedaNCT02932904Written as ParoxetineHow we know
- Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep DisturbanceTerminatedNot applicableSeattle Institute for Biomedical and Clinical ResearchNCT00202449Written as paroxetineHow we know
- Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive DisorderCompletedPhase 3H. Lundbeck A/SNCT02279966Written as Paroxetine 20 mgHow we know
- Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)CompletedPhase 3GlaxoSmithKlineNCT00866294Written as paroxetine IR 10mg tabletHow we know
- An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety DisorderCompletedPhase 2SanofiNCT00374166Written as ParoxetineHow we know
- Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or PlaceboCompletedPhase 1Forest LaboratoriesNCT02097147Written as Paroxetine 20 mgHow we know
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDDCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00445679Written as ParoxetineHow we know
- Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownPhase 4Shanghai Mental Health CenterNCT01764867Written as ParoxetineHow we know
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)TerminatedPhase 3PfizerNCT00658762Written as paroxetineHow we know
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)TerminatedPhase 3PfizerNCT00658372Written as ParoxetineHow we know
Showing 20 of 24.
What changed recently
From the registry's own updates since Oct 20, 2026.
Stopped1
- Management of Acute Tinnitus With Migraine MedicationsSuspendedOct 27, 2026NCT06799169
Codes
What other systems call Paroxetine · ClinicalTrials.gg INT008600
- MeSH (NLM) D017374ParoxetineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 41VRH5220HPAROXETINEConfirmed FDA, NLM, Wikidata
- RxNorm 32937Confirmed FDA, Wikidata
- Wikidata Q27257245paroxetine hydrochlorideConfirmed FDA, NLM, Wikidata
- Wikidata Q408471paroxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61879ParoxetineOne source FDA
- DrugBank DB00715One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017374 | Paroxetine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 41VRH5220H | PAROXETINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 32937 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27257245 | paroxetine hydrochloride | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q408471 | paroxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61879 | Paroxetine | One source FDA |
| DrugBank | DB00715 | — | One source Wikidata |
Also registered as paroxetine acetate (UNII YPO0NTK49O), paroxetine hydrochloride (UNII X2ELS050D8 · RxNorm 1298842), paroxetine hydrochloride anhydrous (UNII 3I3T11UD2S · RxNorm 1311626) and paroxetine maleate (UNII F726G2563Q).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.